Physician profile
Leamon Williams
NPI 1073514451
$545.11
in general payments reported to CMS, 2019-2025
8 companies · $354 in 2025
The $354 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.83 · 2021: $51.06 · 2022: $25.10 · 2023: $25.00 · 2024: $41.14 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $321.58 | 2019-2025 | Aequalis Ascend Flex, Allograft Bio-Implants, Aequalis |
| Depuy Synthes Sales INC. | $68.50 | 2024-2025 | Na |
| Biocomposites INC | $45.93 | 2025 | Stimulan |
| Innovation Technologies INC | $31.18 | 2025 | Irrisept |
| Alon Medical Technology | $27.82 | 2025 | |
| Crossroads Orthopedics, LLC | $25.10 | 2022 | |
| Zimmer Biomet Holdings, INC. | $25.00 | 2023 | Tapestry |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leamon Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.